179) Cancer patients with comorbid conditions h |
180) In a case-control study of 801 bladder cancer patients and 801 matched controls, |
181) e as the most important coping method for cancer patients confirms the result obtain |
182) uently mutated gene, with 30-50% of colon cancer patients harboring activating K-Ras |
183) lts obtained in a qualitative study among cancer patients in Sweden (Ahmadi, Culture |
184) en the most important coping method among cancer patients in Sweden. |
185) chondrial DNA (mtDNA) genomes for 10 lung cancer patients including the primary canc |
186) d in successful transition of hematologic cancer patients into hospice unit in their |
187) t navigation program for Chinese-speaking cancer patients is feasible. |
188) also predicts the responsiveness of colon cancer patients to inhibitors of EGFR sign |
189) ion and treatment in surveillance of anal cancer patients will help prevent local re |
190) ll be exemplified on a data set of breast cancer patients with death as absorbing st |
191) 1, we recruited 28 breast and gynecologic cancer patients. |
192) inues to have a high prevalence in breast cancer patients. |
193) of the somatic mutations in Chinese lung cancer patients. |
194) ity while retaining antitumor efficacy in cancer patients. |
195) rrelated with tumor progression in breast cancer patients. |
196) s plays an important role in mortality of cancer patients. |
197) s known to occur in both canine and human cancer patients. |
198) ET scans coming from seven lung and liver cancer patients. |
199) rtality after esophagectomy in esophageal cancer patients. |
200) nd character its spectrum in Chinese lung cancer patients. |
201) rogram for Chinese gynecologic and breast cancer patients. |
202) The Prostate Cancer in a Black Population (PCBP) Study, |
203) ith, very treatable, node negative breast cancer in California between 1996 and 2000 |
204) n passive tobacco smoke and female breast cancer in China. |
205) used to analyze the incidence of thyroid cancer in Shanghai, China, from 1983 to 20 |
206) of adjuvant treatments of stage III colon cancer in a population-based observational |
207) ADH1C (1-2) increased the risk of breast cancer in drinkers (OR = 1.35; 95% CI = 1. |
208) ribute to the etiology of sporadic breast cancer in non-Hispanic white women aged |
209) ites of TYMS with risk of sporadic breast cancer in non-Hispanic white women aged |
210) AhR agonists as a risk factor for breast cancer in offspring through epigenetic inh |
211) besity, which is a risk factor for breast cancer in postmenopausal women, and in par |
|